vs

Side-by-side financial comparison of Equinix (EQIX) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Equinix is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 0.0%, a 4.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 9.0%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-596.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 5.4%).

Equinix Inc. is an American multinational company headquartered in Redwood City, California. It specialized in internet connectivity and data center colocation centers, commonly known as carrier hotels until the company converted to a real estate investment trust (REIT) in January 2015.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

EQIX vs ONC — Head-to-Head

Bigger by revenue
EQIX
EQIX
1.6× larger
EQIX
$2.4B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+23.8% gap
ONC
32.8%
9.0%
EQIX
Higher net margin
ONC
ONC
4.4% more per $
ONC
4.4%
0.0%
EQIX
More free cash flow
ONC
ONC
$975.8M more FCF
ONC
$379.8M
$-596.0M
EQIX
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
5.4%
EQIX

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
EQIX
EQIX
ONC
ONC
Revenue
$2.4B
$1.5B
Net Profit
$415.0K
$66.5M
Gross Margin
0.1%
90.5%
Operating Margin
0.0%
12.4%
Net Margin
0.0%
4.4%
Revenue YoY
9.0%
32.8%
Net Profit YoY
21.0%
143.8%
EPS (diluted)
$0.00
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EQIX
EQIX
ONC
ONC
Q2 26
$2.4B
Q1 26
$2.4B
Q4 25
$2.4B
$1.5B
Q3 25
$2.3B
$1.4B
Q2 25
$2.3B
$1.3B
Q1 25
$2.2B
$1.1B
Q4 24
$2.3B
$1.1B
Q3 24
$2.2B
$1.0B
Net Profit
EQIX
EQIX
ONC
ONC
Q2 26
$415.0K
Q1 26
$265.0M
Q4 25
$265.0M
$66.5M
Q3 25
$374.0M
$124.8M
Q2 25
$368.0M
$94.3M
Q1 25
$343.0M
$1.3M
Q4 24
$-14.0M
$-151.9M
Q3 24
$297.0M
$-121.3M
Gross Margin
EQIX
EQIX
ONC
ONC
Q2 26
0.1%
Q1 26
50.5%
Q4 25
50.5%
90.5%
Q3 25
50.7%
86.1%
Q2 25
52.0%
87.5%
Q1 25
51.3%
85.2%
Q4 24
47.1%
85.8%
Q3 24
50.1%
83.0%
Operating Margin
EQIX
EQIX
ONC
ONC
Q2 26
0.0%
Q1 26
17.4%
Q4 25
17.4%
12.4%
Q3 25
20.5%
11.5%
Q2 25
21.9%
6.7%
Q1 25
20.6%
1.0%
Q4 24
4.6%
-7.0%
Q3 24
19.3%
-12.0%
Net Margin
EQIX
EQIX
ONC
ONC
Q2 26
0.0%
Q1 26
11.0%
Q4 25
11.0%
4.4%
Q3 25
16.1%
8.8%
Q2 25
16.3%
7.2%
Q1 25
15.4%
0.1%
Q4 24
-0.6%
-13.5%
Q3 24
13.5%
-12.1%
EPS (diluted)
EQIX
EQIX
ONC
ONC
Q2 26
$0.00
Q1 26
$2.70
Q4 25
$2.70
$0.05
Q3 25
$3.81
$0.08
Q2 25
$3.75
$0.06
Q1 25
$3.50
$0.00
Q4 24
$-0.19
$-0.10
Q3 24
$3.10
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EQIX
EQIX
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$3.1B
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$14.3B
$4.4B
Total Assets
$40.9B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EQIX
EQIX
ONC
ONC
Q2 26
$3.1B
Q1 26
$3.2B
Q4 25
$3.2B
$4.5B
Q3 25
$2.9B
$4.0B
Q2 25
$4.5B
$2.8B
Q1 25
$3.7B
$2.5B
Q4 24
$3.6B
$2.6B
Q3 24
$3.2B
$2.7B
Total Debt
EQIX
EQIX
ONC
ONC
Q2 26
Q1 26
Q4 25
$836.4M
Q3 25
$17.3B
Q2 25
$18.1B
Q1 25
$15.9B
Q4 24
$15.3B
Q3 24
$15.4B
Stockholders' Equity
EQIX
EQIX
ONC
ONC
Q2 26
$14.3B
Q1 26
$14.2B
Q4 25
$14.2B
$4.4B
Q3 25
$14.2B
$4.1B
Q2 25
$14.1B
$3.8B
Q1 25
$13.9B
$3.5B
Q4 24
$13.5B
$3.3B
Q3 24
$13.6B
$3.4B
Total Assets
EQIX
EQIX
ONC
ONC
Q2 26
$40.9B
Q1 26
$40.1B
Q4 25
$40.1B
$8.2B
Q3 25
$38.1B
$7.6B
Q2 25
$38.8B
$6.3B
Q1 25
$36.1B
$5.8B
Q4 24
$35.1B
$5.9B
Q3 24
$35.4B
$5.8B
Debt / Equity
EQIX
EQIX
ONC
ONC
Q2 26
Q1 26
Q4 25
0.19×
Q3 25
1.22×
Q2 25
1.28×
Q1 25
1.14×
Q4 24
1.13×
Q3 24
1.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EQIX
EQIX
ONC
ONC
Operating Cash FlowLast quarter
$717.0M
$417.3M
Free Cash FlowOCF − Capex
$-596.0M
$379.8M
FCF MarginFCF / Revenue
-24.4%
25.4%
Capex IntensityCapex / Revenue
0.0%
2.5%
Cash ConversionOCF / Net Profit
1727.71×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EQIX
EQIX
ONC
ONC
Q2 26
$717.0M
Q1 26
Q4 25
$1.1B
$417.3M
Q3 25
$1.0B
$402.6M
Q2 25
$944.0M
$263.6M
Q1 25
$809.0M
$44.1M
Q4 24
$981.0M
$75.2M
Q3 24
$758.0M
$188.4M
Free Cash Flow
EQIX
EQIX
ONC
ONC
Q2 26
$-596.0M
Q1 26
Q4 25
$-292.0M
$379.8M
Q3 25
$-122.0M
$354.5M
Q2 25
$-45.0M
$219.8M
Q1 25
$59.0M
$-12.3M
Q4 24
$-6.0M
$-17.3M
Q3 24
$34.0M
$54.7M
FCF Margin
EQIX
EQIX
ONC
ONC
Q2 26
-24.4%
Q1 26
Q4 25
-12.1%
25.4%
Q3 25
-5.3%
25.1%
Q2 25
-2.0%
16.7%
Q1 25
2.7%
-1.1%
Q4 24
-0.3%
-1.5%
Q3 24
1.5%
5.5%
Capex Intensity
EQIX
EQIX
ONC
ONC
Q2 26
0.0%
Q1 26
Q4 25
59.3%
2.5%
Q3 25
49.1%
3.4%
Q2 25
43.8%
3.3%
Q1 25
33.7%
5.0%
Q4 24
43.7%
8.2%
Q3 24
32.9%
13.3%
Cash Conversion
EQIX
EQIX
ONC
ONC
Q2 26
1727.71×
Q1 26
Q4 25
4.32×
6.28×
Q3 25
2.71×
3.22×
Q2 25
2.57×
2.79×
Q1 25
2.36×
34.71×
Q4 24
Q3 24
2.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EQIX
EQIX

Recurring revenues$1.0B43%
Colocation$731.0M30%
Other$314.0M13%
Interconnection$251.0M10%
Managed infrastructure$57.0M2%
Non-recurring revenues$45.0M2%

ONC
ONC

Segment breakdown not available.

Related Comparisons